The SPAC said a virtual meeting of shareholders will be scheduled in early 2021. Nuvation Bio is focused on developing cancer treatments. Read more.
Related Posts
Priveterra Acquisition Adjourns Aeon Merger Vote for the 4th Time
As with the previous postponements, the latest is “to allow additional time for the company to engage with its stockholders,” Priveterra said in the filing.
Clean-Tech SPAC Silver Sustainable Solutions Files for $250M IPO
The SPAC is backed by Guggenheim Partners.
Bronfman’s Waverley 1 SPAC Cuts Deal Size by 33% Ahead of $200M IPO
The new SPAC said in the filing it will work to acquire a business focused on media, technology or entertainment.
Pivotal Investment III Pushes Extension Vote Back Until Tomorrow
The SPAC is soliciting stockholders to reverse redemptions.